Does antimicrobial lock solution reduce catheter-related infections in hemodialysis patients with central venous catheters? A Bayesian network meta-analysis

International Urology and Nephrology

Volumn 49, Issue 4, 2017, Pages 701-716

  Zhang, Jun ^a   Wang, Bo ^b   Li, Rongke ^a   Ge, Long ^c   Chen, Kee Hsin ^d,e   Tian, Jinhui ^c  

^a GANSU UNIVERSITY OF CHINESE MEDICINE   (China)

^b Rehabilitation Center Hospital of Gansu   (China)

^c LANZHOU UNIVERSITY   (China)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial lock solution; Catheter related infections; Central venous catheters; Network meta analysis; Renal dialysis

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; ANTIMICROBIAL LOCK SOLUTION; CEFOTAXIME; CITRIC ACID; GENTAMICIN; HEPARIN; MINOCYCLINE; TAUROLIDINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTICOAGULANT AGENT;

APPLICATION SITE INFECTION; ARTICLE; BAYES THEOREM; CATHETER INFECTION; CAUSE OF DEATH; CENTRAL VENOUS CATHETER; DRUG EFFICACY; HEMODIALYSIS PATIENT; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADULT; ADVERSE DEVICE EFFECT; CATHETER-RELATED INFECTIONS; HEMODIALYSIS; MICROBIOLOGY; NETWORK META-ANALYSIS;

ADULT; ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; BAYES THEOREM; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; CITRIC ACID; GENTAMICINS; HEPARIN; HUMANS; NETWORK META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS;

EID: 85007484092     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-016-1490-x     Document Type: Article

References (46)

1. Rehman R, Schmidt RJ, Moss AH (2009) Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol 4:456–460
2. Rayner HC, Besarab A, Brown WW et al (2004) Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 44:22–26
3. Pisoni RL, Young EW, Dykstra DM et al (2002) Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 61:305–316
4. Lacson E Jr, Lazarus JM, Himmelfarb J et al (2007) Balancing fistula first with catheters last. Am J Kidney Dis 50:379–395
5. Taylor G, Gravel D, Johnston L et al (2002) Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 23:716–720
6. Silva TN, de Marchi D, Mendes ML et al (2014) Approach to prophylactic measures for central venous catheter-related infections in hemodialysis: a critical review. Hemodial Int 18:15–23
7. Katneni R, Hedayati SS (2007) Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephrol 3:256–266
8. Ishani A, Collins AJ, Herzog CA et al (2005) Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 68:311–318
9. Engemann JJ, Friedman JY, Reed SD et al (2005) Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 26:534–539
10. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322
11. Donlan RM (2001) Biofilm formation: a clinically relevant microbiologic process. Clin Infect Dis 33:1387–1392
12. Lewis K (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45:999–1007
13. Dogra GK, Herson H, Hutchison B et al (2002) Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 13:2133–2139
14. Betjes MG, van Agteren M (2004) Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 19:1546–1551
15. Bleyer AJ, Mason L, Russell G et al (2005) A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26:520–524
16. Snaterse M, Rüger W, Scholte Op Reimer WJ et al (2010) Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 75:1–11
17. Rabindranath KS, Bansal T, Adams J et al (2009) Systematic review of antimicrobials for the prevention of hemodialysis catheter-related infections. Nephrol Dial Transplant 24:3763–3774
18. Yahav D, Rozen-Zvi B, Gafter-Gvili A et al (2008) Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 47:83–93
19. Liu H, Liu H, Deng J et al (2014) Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. Blood Purif 37:179–187
20. Zhao Y, Li Z, Zhang L et al (2014) Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis 63:479–490
21. Lu G, Ades AE (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23:3105–3124
22. Jansen JP, Crawford B, Bergman G et al (2008) Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 11:956–964
23. Catalá-López F, Tobías A, Cameron C et al (2014) Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int 34:1489–1496
24. O’Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51:1–29
25. Higgins JP, Altman DG, Gøtzsche PC et al (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928
26. Shriner D, Yi N (2009) Deviance information criterion (DIC) in Bayesian multiple QTL mapping. Comput Stat Data Anal 53:1850–1860
27. Brooks SP, Gelman A (1998) General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 7:434–445
28. McIntyre CW, Hulme LJ, Taal M et al (2004) Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 66:801–805
29. Saxena AK, Panhotra BR (2005) The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. J Nephrol 18:755–763
30. Weijmer MC, van den Dorpel MA, Van de Ven PJ et al (2005) Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 16:2769–2777
31. Nori US, Manoharan A, Yee J et al (2006) Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48:596–605
32. Macrae JM, Dojcinovic I, Djurdjev O et al (2009) Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 3:369–374
33. Tan HZ (2008) A randomized controlled study on prevention of catheter-related bacteremia with gentamicin-heparin lock solution. Dissertation, Zhejiang University
34. Zhang P, Yuan J, Tan H et al (2009) Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purif 27:206–211
35. Solomon LR, Cheesbrough JS, Ebah L et al (2010) A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis 55:1060–1068
36. Campos RP, do Nascimento MM, Chula DC et al (2011) Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol 22:1939–1945
37. Filiopoulos V, Hadjiyannakos D, Koutis I et al (2011) Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial. Am J Nephrol 33:260–268
38. Lu DS (2011) Gentamicin lock solution prevents central venous catheter-related infections in hemodialysis. Med Inform 24:123–124
39. Broom JK, Krishnasamy R, Hawley CM et al (2012) A randomised controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in hemodialysis patients–the HEALTHY-CATH trial. BMC Nephrol 13:146
40. Moran J, Sun S, Khababa I et al (2012) A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 59:102–107
41. Sofroniadou S, Revela I, Smirloglou D et al (2012) Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study. Semin Dial 25:344–350
42. Hu ZX, Xiao HQ, Fei P (2013) Application of the lock solution containing l% cefazolin/30% sodium citrate for long-term indwelling catheters in maintenance hemodialysis patient. Chin J Blood Purif 12:602–604
43. Zacharioudakis IM, Zervou FN, Arvanitis M et al (2014) Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin Infect Dis 59:1741–1749
44. Oliver MJ, Callery SM, Thorpe KE et al (2000) Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 58:2543–2545
45. Wang AY, Ivany JN, Perkovic V et al (2013) Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Nephrol Dial Transplant 28:2875–2888
46. Landry DL, Braden GL, Gobeille SL et al (2010) Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 5:1799–1804